Ryan G. Holstead
University of Massachusetts Chan Medical School · 20 works · 291 citations · h-index 11
Top works
- Discussing Serious News Remotely: Navigating Difficult Conversations During a Pandemic
- Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma
- Emergency Department Utilization for Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis of Identification and Outcomes for Those Presenting for Immune-Related Adverse Events
- Serum Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Prognosticating Immunotherapy Efficacy
- Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer
- Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases
- Impact of the development of immune related adverse events in metastatic melanoma treated with PD -1 inhibitors
- Functional Differences in Pore Properties Between Wild-Type and Cysteine-Less Forms of the CFTR Chloride Channel
- Regulation of CFTR chloride channel macroscopic conductance by extracellular bicarbonate
- Prognosticating Role of Serum Eosinophils on Immunotherapy Efficacy in Patients with Advanced Melanoma
- Identifying Patterns of Failure and Secondary Primary Malignancies in HPV-Related Oropharyngeal Squamous Cell Carcinomas
- Utility of Large Language Models to Produce a Patient-Friendly Summary From Oncology Consultations
- A Systematic Review and Meta-analysis of Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favourable Risk
- No Association Between BMI and Immunotoxicity or Clinical Outcomes for Immune Checkpoint Inhibitors
- Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer
- Global interest in podcasts designed for medical oncology trainees.
- Comparison of mortality and second primary oropharyngeal malignancies by human papilloma virus (HPV) status in patients (pts) with oropharyngeal squamous cell carcinoma (OPSCC) using an updated Surveillance, Epidemiology, and End Results (SEER) database.
- Survival outcomes in localized pancreatic cancer treated with neoadjuvant chemotherapy (NAC).
- Characteristics and outcomes of patients (pts) who developed immune-related adverse events (irAEs) with an initial presentation in the emergency department (ED).
- Should surveillance guidelines be different based on Human Papilloma Virus (HPV) status? Patterns of failure and second primary cancers (SPM) in patients (pts) with oropharyngeal squamous cell cancer (OPSCC).